AEON Biopharma (AEON) Earnings Date & Reports

AEON Biopharma Inc is a biopharmaceutical company focused on the development of ABP-450 (prabotulinumtoxinA), a biosimilar to Botox (onabotulinumtoxinA), for therapeutic indications... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

AEON is expected to report earnings to rise 300.00% to -7 cents per share on November 18

AEON Biopharma AEON Stock Earnings Reports

Q3'26

Est.

$-0.08

Q2'26

Beat

by $0.63

Q4'25

Missed

by $2.64

Q3'25

Missed

by $0.07

Q2'25

Missed

by $0.29

The last earnings report on August 12 showed earnings per share of -1 cents, beating the estimate of -64 cents. With 1.48M shares outstanding, the current market capitalization sits at 13.05M.

View a ticker or compare two or three

AEON

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for AEON